✦ LIBER ✦

Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: A prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ Scribed by El-Sawaf, Mohamed; Siddiqui, Sabina; Mahmoud, Moustafa; Drongowski, Robert; Teitelbaum, Daniel H.

Book ID: 120684246
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 217 KB
Volume: 48
Category: Article
ISSN: 0022-3468
DOI: 10.1016/j.jpedsurg.2012.10.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Probiotic prophylaxis after pullthrough

Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: A prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ El-Sawaf, Mohamed; Siddiqui, Sabina; Mahmoud, Moustafa; Drongowski, Robert; Teit 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 217 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement

✍ Elizabeth L. Sampson; Peter R. Raven; Patricia N. Ndhlovu; Aaron Vallance; Nicho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract ## Objectives This was a pilot, phase 2a study to assess methodological feasibility and the safety and efficacy of donepezil in preventing postoperative delirium after elective total hip replacement surgery in older people without pre‐existing dementia. The hypothesis was that donepezi

Results of a prospective, randomized, do

Results of a prospective, randomized, double-blind, placebo-controlled, dose-ranging trial to determine the effective dose of ramosetron for the prevention of vomiting after tonsillectomy in children

✍ Yoshitaka Fujii; Hiroyoshi Tanaka 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Corrigendum to: “A First Prospective, Ra

Corrigendum to: “A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease” [Eur Urol 2009;56:363-70]

✍ Alessandro Palmieri; Ciro Imbimbo; Nicola Longo; Ferdinando Fusco; Paolo Verze; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A phase 3 multicenter, randomized, doubl

A phase 3 multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of the Sufentanil NanoTab PCA System for the treatment of post-operative pain after open abdominal surgery

✍ Royal, M.; Minkowitz, H.; Ringold, F.; Gan, T.; Palmer, P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB